Insulin Delivery Devices Market
Report ID: SQMIG35B2261
Report ID: SQMIG35B2261
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35B2261 |
Region:
Global |
Published Date: January, 2026
Pages:
184
|Tables:
89
|Figures:
69
Global Insulin Delivery Devices Market size was valued at USD 18.02 Billion in 2024 and is poised to grow from USD 19.44 Billion in 2025 to USD 35.72 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026–2033).
The global insulin delivery of devices for market growth is driven due to the global increase in diabetes. The demand for more advanced, sophisticated, and user-friendly diabetes management systems has increased because of this.
Moreover, the market is expected to grow even further as previously mentioned digital technologies begin to become integrated into the devices used for delivery of insulin. This includes the emergence of Continuous Glucose Monitoring (CGM) systems, which will utilize insulin delivery devices to adjust insulin doses automatically and in real-time while monitoring blood glucose hormone levels continuously.
Wearable and patch insulin pumps have gained importance in the list of discreet and convenient options available to administer continuous infusion rates of insulin. In January 2024, PharmaSens put in an application to the FDA for approval of its patch insulin pump system, named niia essential, in the United States. This application represents a huge advancement for PharmaSens and represents innovation in the technology for insulin pumps.
How is Innovation Shaping the Future of Insulin Delivery Devices?
The global insulin delivery devices industry is built on innovation. Manufacturers are continuously developing technology that will enhance the efficacy, simplicity, and pain points of insulin delivery. Innovations include closed-loop devices that provide real-time dosing adjustments based upon continuous glucose monitoring, patch pumps that dispense insulin without tubings and stick to the skin, and smart insulin pens that capture the dose and time of each administration. Medtronic plc received the CE Mark for their MiniMed 780G system in January 2024, which includes the Simplera Sync – a new, single-use, integrated continuous glucose monitor (CGM) that entirely removes the need for fingersticks or additional adhesive. The Simplera Sync is significantly smaller than Medtronic's previous sensor models and can set up in just two steps. In the spring of 2024, a small sample size of MiniMed 780G devices with the Simplera Sync sensor will be deployed in Europe, with a planned gradual rollout throughout Europe in the summer of 2024.
Market snapshot - 2026-2033
Global Market Size
USD 16.7 billion
Largest Segment
Homecare
Fastest Growth
Hospitals & Clinics
Growth Rate
7.9% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Insulin Delivery Devices Market is segmented by Product Type, Diabetes Type, End-User and region. Based on Product Type, the market is segmented into Insulin Pens, Insulin Pumps (Tethered), Insulin Pumps (Tubeless / Patch), Insulin Syringes & Needles and Smart Insulin Delivery Devices. Based on Diabetes Type, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other Special Populations. Based on End-User, the market is segmented into Home Care / Self-administration, Hospitals & Clinics and Specialized Diabetes Care Centres. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per the 2024 insulin delivery devices market analysis, the insulin pens segment held the highest market share at 43.68%. Overall, insulin pens are advisable to provide insulin in a manner that is easy to use, accurate, and less invasive. They are particularly advantageous for people with diabetes who need to regularly inject insulin. According to data from the MSF-SA Association (May 2024), a survey commissioned by MSF and T1International reached out to 38 countries and over 400 individuals who administer insulin, and they found that 82% of respondents who had used both insulin pens and standard syringes preferred insulin pens.
The insulin pumps segment is projected to grow at the highest rate in the next couple of years. Insulin pumps provide a reliable and accurate way to inject insulin in people with diabetes. These devices are small and portable and administer insulin through a small tube placed under the skin, like how a healthy pancreas works. They deliver a basal infusion of insulin throughout the day, as well as extra incremental doses or boluses at mealtimes.
As per the 2024 insulin delivery devices market forecast, the homecare segment dominated the market with about 48.21% of total revenue. Homecare makes a huge difference in the insulin delivery segment considering that it allows the patient to manage his or her diabetes from home. Many goods and services are available away from the doctor's clinic to assist diabetic patients in administering and/or monitoring and managing their insulin doses. Homecare companies market a wide variety of insulin delivery devices, including pens, syringes, pumps, and continuous glucose monitoring (CGM) systems. With the help of these products, patients can self-administer insulin doses with relative accuracy and monitor their blood sugar levels without continuous doctor visits.
Whereas the highest CAGR of 8.42% is predicted to occur in the hospitals & clinics segment over the forecast period. These establishments play an important role in insulin delivery as they are where patients go for diagnosis, treatment, and management of diabetes. Assorted means of insulin delivery are utilized in a hospital setting based on the different needs of patients. Among these means are syringes, insulin pumps, insulin pens, and the like. For example, a study by the American Medical Association in February 2024 found that home insulin pumps are safe for kids in non-critical care units of a children's hospital, particularly for treating hyperglycemia and hypoglycemia.
To get detailed segments analysis, Request a Free Sample Report
As per the insulin delivery devices market regional analysis, North America dominated the market due to an alarming prevalence of diabetes, a very well-established healthcare system, and fast integration of new technologies. In 2024 doors will be opened for FDA-approved smart insulin pens and patch pumps, making the lives of patients easier. The increasing investments in continuous glucose monitoring (CGM) systems and integration of digital health will help spur the growth of this market in this region. North America would offer significant opportunities for their growth as it would encourage product reimbursement policies.
Of its vast number of diabetic patients and innovative concepts, it has also demonstrated that the US has the highest insulin delivery devices market share. In January 2024, Medtronic announced that it had started testing closed-loop insulin systems of the next generation in the United States. This showed how automated these things are nowadays. Major efforts at smart device use are speeding up with strong collaborations between IT companies and healthcare professionals. Hospitals, clinics, and home care continue to see most demand due to reimbursement of assistance and increased awareness.
The Canadian market share continuously rises in insulin delivery devices. In fact, this is due to the rise in type 2 diabetes cases and government-funded initiatives in healthcare. In 2024, Diabetes Canada would emphasize better coverage schemes to improve access for patients to insulin pumps; it is therefore a promising market for innovations in user-friendly delivery solutions, as by then even increased demand for smart monitoring systems and home-based insulin administration is projected.
Insulin pens, insulin pumps, and CGMs still have a cross-section use all over Europe. Some parts of Europe already had the release of the MiniMed 780G system integrated with the Simplera Sync CGM from Medtronic by 2024. This made users much easier for users to handle their devices. Patronage of the new technology increases in the region due to several factors, a strong emphasis on patient safety, encouraging reimbursement policies, and increased awareness. Therefore, the European economy will grow gradually with developing features for the next years onward.
The European insulin delivery devices sector is slowly developing owing to the NHS efforts to better diabetes care and newer treatment technologies that benefit patients. The NHS expanded coverage for CGMs and insulin pumps in the year 2024 and use increased with those enhancements. Home-based diabetes management revolves around convenience, and there are more patients using insulin pens and devices that can be smart for this reason. Most fast-growing incidence of type 2 diabetes in the country is responsible for the rising demand.
The prevalence of diabetes in France is therefore linked to the insulin delivery devices market in the country, as its Statutory Health Insurance (SHI) covers diabetes fully, as the most common chronic disease in France. Over the last ten years, the number of beneficiaries has doubled; around a million French people are suffering from diabetes, according to the WHO. Diabetes is becoming common among all ages due to obesity, bad diets, and lack of physical activity. Also, type 1 diabetes occurs in approximately 0.26 million people.
The insulin delivery devices market is booming with Germany. The cause behind this fast-moving expansion is the rising level of aging and increasing cases of diabetes. Diabetes remains a major health problem in Germany's healthcare systems. Most adults have types 1 and 2 diabetes without even knowing they are sick. The number of people expected to increase over the next years will be due to increasing age and poor lifestyle decisions, resulting in an unsatisfactory condition of type 2 diabetes.
The fastest expansion in the insulin delivery devices market among regions in the assessed period is expected to take place in Asia-Pacific, with an annual growth of 8.8%. The Asia Pacific market which is the primary contributor to China and Japan. China concluded having the largest market for insulin delivery devices in terms of revenue share. This is attributed to an increase in diabetes and a number of key players in the industry. Other important factors propelling market growth include advancements in insulin delivery devices, an aging population, and a surge in lifestyle diseases, especially obesity. According to IDF, 20–79-year-old, many adults had diabetes in the IDF South-East Asia (SEA) Region in 2021, increasing the figure to 152 million by 2045. Around 206 million adults aged 20 79 will be having diabetes in 2021 in IDF Western Pacific Region. In 2045, the figure is expected to increase to 260 million.
Among the rapidly increasing countries with markets for insulin delivery devices, China takes the lead. Most citizens are suffering from the effects of having changed lifestyles and migrated into urban areas that bring diabetes. In 2024, Chinese companies joined hands with international businesses in producing affordable insulin pens and patch pumps. Government-sponsored initiatives promote smart-integrated healthcare and raise awareness around diabetes to speed up the population's consumption of these technologies. As healthcare costs continue to rise in the middle class, it is likely that China would continue to be a major driving force in the region.
While the number of diabetic people over the age of 65 increases in Japan, it is the index that starts to contribute to the nation's economic growth. There are designs for very compact and user-friendly insulin pumps intended for use at home by local industries. In 2024, Japan would fast track the adoption of CGM-integrated insulin delivery systems, particularly for the aged. The development of this market is likely to continue to progress steadily because of the strong emphasis on precision medicine by the country's government. This says that there will be many openings for devices of next generations.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Rising Acceptance of Smart and Connected Devices
More People are Becoming Diabetic and in Need of Care
Issues with Costs and Reimbursement
Interoperability Issues and Complexity of Technology
Request Free Customization of this report to help us to meet your business objectives.
There are numerous market competitors in insulin delivery devices. Large pharmaceutical and medtech firms dominate due to their robust sales channels and expertise with government regulations. In contrast, nimble startups and small device companies drive product innovation. Companies compete daily on how accurate, easy to use, compatible, and economical their insulin therapy is. A major hallmark of strategic initiatives in 2024 and 2025, such as buying companies, partnerships with CGM companies, and investment in software, was the design of unified, scientifically informed solutions that payers and health systems would find attractive.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the insulin delivery devices market is entering a new phase that is more consumer-centered and technology-connected. Despite the proliferation of nimble startups driving user-friendly advances like patch pumps, smart pens, and closed-loop systems, larger medtech and pharmaceutical companies continue to focus on creating larger companies in a regulated environment. Diabetes prevalence will primarily be the continuing source of growth and transition to value-based and remote care. The main challenges are still the difficulties of interoperability, costs, and reimbursement. Smaller pumps and new combinations of devices and software were the top priorities to last. The total market looks to be performing positively. Companies that can deliver clinician-validated outcomes at accessible prices with seamless digital experience will be best positioned for growth 10 years ahead.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 18.02 Billion |
| Market size value in 2033 | USD 35.72 Billion |
| Growth Rate | 7.9% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Insulin Delivery Devices Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Insulin Delivery Devices Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Insulin Delivery Devices Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Insulin Delivery Devices Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
